PPD GLOBAL LTD
Operating as a subsidiary of Thermo Fisher Scientific, the business is a contract research organisation that provides clinical trial management, biostatistical analysis, and regulatory advisory services to the pharmaceutical industry.
Get an alert when PPD GLOBAL LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£11M
USD 14,152,000
-95.8% lowest in 3 filed years
Net assets
£219M
USD 292,668,000
+1.2% vs 2024
Employees
2,146
-1.8% lowest in 3 filed years
Profit before tax
£26M
USD 35,397,000
-90.4% lowest in 3 filed years
Watch the reel
Our short-form breakdown of PPD GLOBAL LTD's latest filing
Inside the accounts of PPD Global Ltd: £2.6bn in revenue, a swing to a net loss, and a massive £1.34bn dividend. 💊📉
Net assets
3-year trend · vs Industrials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £1,802,838,748 | £1,909,001,348 | £1,955,151,220 | +2.4% | |
| Operating profit | £221,139,392 | £224,231,172 | £19,705,794 | -91.2% | |
| Profit before tax | £262,678,545 | £276,658,182 | £26,498,727 | -90.4% | |
| Net profit | £183,110,496 | £258,840,395 | -£1,805,660 | -100.7% | |
| Cash | £632,605,929 | £253,132,205 | £10,594,400 | -95.8% | |
| Total assets less current liabilities | £971,131,906 | £218,886,061 | £221,839,347 | +1.3% | |
| Net assets | £969,021,560 | £216,564,605 | £219,095,673 | +1.2% | |
| Equity | £969,021,560 | £216,564,605 | £219,095,673 | +1.2% | |
| Average employees | 2,228 | 2,186 | 2,146 | -1.8% | |
| Wages | £129,540,350 | £134,636,173 | £139,065,728 | +3.3% | |
| Directors' remuneration | £729,151 | £267,256 | £376,553 | +40.9% |
Figures converted to GBP from USD at 0.749 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 12.3% | 11.7% | 1.0% | |
| Net margin | 10.2% | 13.6% | -0.1% | |
| Return on capital employed | 22.8% | 102.4% | 8.9% | |
| Gearing (liabilities / total assets) | 54.1% | 82.4% | 81.4% | |
| Current ratio | 1.84x | 1.20x | 0.97x | |
| Interest cover | — | — | 42.25x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 5 times since incorporation
- PPD GLOBAL LTD 1999-05-20 → present
- PHARMACO INTERNATIONAL LTD 1996-04-16 → 1999-05-20
- PHARMACO UK LIMITED 1992-07-14 → 1996-04-16
- CLINICAL SCIENCE RESEARCH INTERNATIONAL LIMITED 1991-09-18 → 1992-07-14
- CLINICAL SCIENCE RESEARCH LIMITED 1990-04-04 → 1991-09-18
- CAMBRIDGE APPLIED NUTRITION TOXICOLOGY AND BIOSCIENCES LIMITED 1981-05-29 → 1990-04-04
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- S&W Audit
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Having considered the forecasts, available cash resources, and the availability of financial support from the ultimate parent company, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future, being at least 12 months from the date of approval of these financial statements. Accordingly, the directors continue to adopt the going concern basis in preparing the financial statements. The directors have not identified any material uncertainties that would cast significant doubt on the Company's ability to continue as a going concern.”
Group structure
- PPD GLOBAL LTD · parent
- Thermo Fisher Scientific PR Limited 100%
- PPD Slovak Republic s.r.o 15%
- PPD Pharmaceutical Development India Private Limited 1%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 27 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| OAKWOOD CORPORATE SECRETARY LIMITED | Corporate Secretary | 2022-11-30 | — | — |
| ETTEFAGH, Michael Amir | Director | 2025-05-01 | Nov 1972 | American |
| LI-YAN-HUI, Xiao Rong | Director | 2025-05-01 | May 1971 | British |
| STARR, Alison Jane | Director | 2023-12-15 | Jan 1977 | British |
Show 27 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BULL, Helen Ruth | Secretary | 1996-12-13 | 2008-08-08 |
| GREGG, Rhona | Secretary | 2022-11-30 | 2026-03-31 |
| JAMES, Julia Mary | Secretary | 2021-02-01 | 2024-03-31 |
| NEILD, Christopher David | Secretary | 2008-08-08 | 2020-03-19 |
| SERJEANT, Neil Charles | Secretary | — | 1996-06-28 |
| SHANNON, Colin | Secretary | 1996-06-28 | 1996-12-13 |
| AMOS, Harry Edmund | Director | — | 1992-02-28 |
| BRYER, John David | Director | 1996-03-20 | 1997-01-06 |
| BULL, Helen Ruth | Director | 2007-03-27 | 2008-08-08 |
| CHAPUT, Mary Avery | Director | 1995-11-17 | 1996-03-20 |
| DAVENPORT, Fred Blount | Director | 1997-01-06 | 2006-11-09 |
| GEROCK III, Henry Walter | Director | 2024-03-31 | 2025-05-01 |
| GOODSON, Peter Jack Mitford, Doctor | Director | 1994-08-01 | 1996-12-13 |
| HARRIS, Richard Stuart | Director | 2020-03-19 | 2024-03-31 |
| HARTMAN, Brainard Judd | Director | 2006-11-09 | 2014-08-27 |
| JAMES, Julia Mary | Director | 2014-08-27 | 2024-03-31 |
| LEE, Amber Kathleen | Director | 2022-02-01 | 2023-12-15 |
| LOGAN, Kelvin Barry, Doctor | Director | 1992-02-28 | 1994-08-01 |
| NEILD, Christopher David | Director | 2007-11-21 | 2020-03-19 |
| NEILSON, William Robert, Dr | Director | 1997-11-24 | 1998-11-13 |
| NEWBERY, Roger Stephen | Director | 2011-06-08 | 2022-02-01 |
| PACIOS MERINO, Sebastian | Director | 2008-07-25 | 2011-06-08 |
| SHANNON, Colin | Director | 1996-12-13 | 2007-03-27 |
| SHANNON, Colin | Director | 1995-11-17 | 1996-03-20 |
| SHAW, William Lawson, Dr | Director | 1996-06-28 | 1997-11-24 |
| SUMMERFIELD, Peter John Frederick | Director | 2011-06-08 | 2017-06-28 |
| WAECHTER, Stephen Lawrence | Director | 1995-11-17 | 1997-01-06 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Ppd Uk Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 217 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-06-29 | AA | accounts | Accounts with accounts type full | |
| 2026-04-01 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-10-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-11 | AA | accounts | Accounts with accounts type full | |
| 2025-05-23 | AP01 | officers | Appoint person director company with name date | |
| 2025-05-22 | AP01 | officers | Appoint person director company with name date | |
| 2025-05-06 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-10 | AA | accounts | Accounts with accounts type full | |
| 2024-10-08 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-08-22 | RP04AP01 | officers | Second filing of director appointment with name | |
| 2024-07-26 | RP04AP01 | officers | Second filing of director appointment with name | |
| 2024-04-17 | TM01 | officers | Termination director company with name termination date | |
| 2024-04-02 | AP01 | officers | Appoint person director company with name date | |
| 2024-04-02 | TM01 | officers | Termination director company with name termination date | |
| 2024-04-02 | TM02 | officers | Termination secretary company with name termination date | |
| 2023-12-19 | AP01 | officers | Appoint person director company with name date | |
| 2023-12-18 | TM01 | officers | Termination director company with name termination date | |
| 2023-10-04 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-08-14 | AA | accounts | Accounts with accounts type full | |
| 2022-12-12 | AA | accounts | Accounts with accounts type group |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.